John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 99,980 shares at $3.40 ($340K) on 2021-03-01, disclosed to the SEC on 2021-03-02.
Seasonal sale ($340k) by CEO and President — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.40 | 24,674 | $84K | 24.7% |
| 2 | $3.40 | 24,674 | $84K | 24.7% |
| 3 | $3.40 | 25,316 | $86K | 25.3% |
| 4 | $3.40 | 25,316 | $86K | 25.3% |
| Total | $3.40 avg | 99,980 | $340K | 100% |
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |